News

Cyclo Therapeutics, Inc., a clinical-stage biotechnology company that develops cyclodextrin-based products for the treatment of Niemann-Pick Disease Type C and Alzheimer’s Disease,…
Read More...

Boehringer Ingelheim presented promising preclinical data from its pan-KRAS program including the novel, oral inhibitor BI 1701963 at the AACR-NCI-EORTC International Conference on…
Read More...

Themis Bioscience and CEPI – the Coalition for Epidemic Preparedness Innovations – announced the first administration to healthy volunteers in a Phase 1 clinical trial with Themis’…
Read More...

The European Commission (EC) approved a new indication for Dupixent (dupilumab) in chronic rhinosinusitis with nasal polyposis (CRSwNP). Dupixent is indicated as an add-on therapy with…
Read More...

Enesi Pharma, the innovative pharmaceutical company developing unique injectable solid dose drug-device vaccine products, is delighted to announce that it has been awarded grant funding…
Read More...

Merck KGaA, Darmstadt, Germany, which operates its biopharmaceutical business as EMD Serono in the US and Canada, and Pfizer Inc. announced that the European Commission (EC) has…
Read More...

GlaxoSmithKline plc announced that patient dosing has begun in a phase III clinical programme investigating gepotidacin, the first in a new chemical class of antibiotics called…
Read More...

Ziopharm Oncology and The University of Texas MD Anderson Cancer Center announced a new research and development agreement relating to Ziopharm’s Sleeping Beauty immunotherapy program…
Read More...

CARsgen Therapeutics Co. Ltd., a clinical-stage biopharmaceutical company announced that the United States Food and Drug Administration (FDA) has granted Regenerative Medicine Advanced…
Read More...

Gilead Sciences Inc. and Glympse Bio, Inc., announced that the companies have entered into a strategic collaboration in nonalcoholic steatohepatitis (NASH) clinical development. Glympse…
Read More...

HistoIndex announces the expansion of its AI-based digital pathology platform towards large-scale NASH preclinical programs for pharmaceutical and biotech companies to achieve…
Read More...

Alvogen and Zentiva Group a.s announced that Alvogen has signed a definitive agreement to sell its Central and Eastern European business to Zentiva, for an undisclosed amount.…
Read More...

Vertex Pharmaceuticals Incorporated announced an access agreement with NHS England for all currently licensed Vertex cystic fibrosis (CF) medicines and any future indications of these…
Read More...

Novartis announced that the European Commission (EC) has approved a label update for the up-titration of Cosentyx (secukinumab) to 300 mg for patients with active ankylosing spondylitis…
Read More...

Allergan plc announced that the U.S. Food and Drug Administration (FDA) approved the company's supplemental Biologics License Application (sBLA) for BOTOX for the treatment of pediatric…
Read More...

AZTherapies, Inc., a biopharmaceutical company developing therapeutics to extend brain health, announced the acquisition of Smith Therapeutics, a private biopharmaceutical company with…
Read More...

AVROBIO announced that the U.S. Food and Drug Administration (FDA) has granted orphan-drug designation for the Company’s investigational gene therapy, AVR-RD-02, for the treatment of…
Read More...

Foamix Pharmaceuticals Ltd. announced that it has entered into a long term contract manufacturing and supply agreement with ASM Aerosol-Service for the Company’s recently approved…
Read More...

Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis, announced it has entered into…
Read More...

The Janssen Pharmaceutical Companies of Johnson & Johnson announced the submission of a Type II Variation Application to the European Medicines Agency (EMA) seeking first-in-class…
Read More...